Antipodes Partners’s Honeywell HON Stock Holding History
Bought
Maintained
Sold
Other funds holding HON
Antipodes Partners's HON Position: Q2 2026 in Review
Antipodes Partners reduced its Honeywell (HON) stake by 46% in Q2 2026, selling an estimated $16.5M and leaving 87,115 shares worth $19.5M. The position accounts for 0.36% of the portfolio, ranked #53.
Antipodes Partners first reported a position in HON in Q3 2025 and has held it in 4 quarters since. The position peaked at $36.4M in Q1 2026. 2,151 funds tracked by Wall St. Rank hold HON as of Q2 2026.
- Antipodes Partners held 87,115 shares of Honeywell worth $19.5M as of Q2 2026.
- Antipodes Partners sold 74,101 Honeywell shares in Q2 2026, an estimated $16.5M.
- Honeywell made up 0.36% of Antipodes Partners's portfolio in Q2 2026, its #53 holding.
- Antipodes Partners first reported a position in Honeywell in Q3 2025 and has held it in 4 quarters since.
- Antipodes Partners's Honeywell position peaked at $36.4M in Q1 2026.
- 2,151 funds tracked by Wall St. Rank held Honeywell as of Q2 2026.
Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.